24Mar
24Mar
The Best Canned Wine for Every Palate (Whether You’re into Red, White or Rosé)
"We’re not wine snobs here, which is why we’re fully on board with the canned wine trend. They’re portable, easy to recycle and safe to sip poolside (without risk of broken glass). Not to mention some of the latest brands to hit the market are offering seriously great vino in those 250- to 375-mL containers. After sampling more than a dozen brands on the market—yeah, they call this work, and yeah, we’re hiring—here’s what we’re deeming the best canned wine...
23Mar
Star-Studded Spirits
Mega-watt celebrities, From Elizabeth Banks to Dwayne “The Rock” Johnson, Have Launched Their Own Drink Lines. Raise a Glass to These Brands. List includes Archer Roose. Read more >>
23Mar
Wasabi Technologies Becomes the Official Cloud Storage Partner of the Boston Bruins and TD Garden
Extensive in-game brand integration and high visibility across TD Garden events highlight Wasabi’s global growth in sports, media, and entertainment. Read more >>
23Mar
Meet the FinTech Breakthrough Award Winners
FutureFuel.io wins Best Personal Finance Platform. Read more >>
21Mar
Boston Harbor Angels 7Hs for Founders
This is a list for Founders but also should apply to all stakeholders. Investors, board members, advisors, shareholders, employees, vendors, suppliers... #investingforabetterworld #angelinvesting #startups
17Mar
Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries
Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, and Biolexis, a division of Stelis Biopharma Limited (Stelis), announced today that they have entered into a licensing, manufacturing and commercialization agreement for Akston’s AKS-452, a protein subunit COVID-19 vaccine. Under the agreement, Biolexis gains the right to manufacture and commercialize AKS-452 (branded as AmbiVax-CTM) in India and over 130 countries in Asia, Latin America, and Africa largely covering the low-and-middle-income countries (LMICs). Biolexis will also leverage the capabilities...
17Mar
OmniLife Named a Finalist for the 2022 Innovation Challenge in Kidney Disease by Lyfebulb and CVS Kidney Care®
OmniLife, a health technology integrated communication, workflow, and care coordination platform focused on transplant hospitals, group practices, and ACOs (e.g., KCCs), has been recognized as a finalist for the 2022 Innovation Challenge: Accelerating Innovations in Kidney Disease to Improve Health Equity and Outcomes by the teams at Lyfebulb and CVS Kidney Care®, a CVS Health® company. Read more >>
16Mar
Emovi, Inc. Announces Clinical Collaboration With The Geneva Foundation to Support US Army Soldiers and Veterans Faced With Knee Problems
Emovi, Inc., a leading medical device developer and manufacturer for orthopaedics, announced today a clinical collaboration with the US Army in partnership with The Geneva Foundation and a supporting grant from the Quebec Ministry of Economy and Innovation. With the installation of three KneeKG Systems, the project will demonstrate the functionalities and performance of Emovi's AI Platform combined with its KneeKG technology to the military health system. Read more >>
16Mar